DICLOFENAC SODIUM TOPICAL GEL, 1% and ABDOMINAL DISCOMFORT

5,803 reports of this reaction

1.8% of all DICLOFENAC SODIUM TOPICAL GEL, 1% reports

#5 most reported adverse reaction

Overview

ABDOMINAL DISCOMFORT is the #5 most commonly reported adverse reaction for DICLOFENAC SODIUM TOPICAL GEL, 1%, manufactured by BluePoint Laboratories. There are 5,803 FDA adverse event reports linking DICLOFENAC SODIUM TOPICAL GEL, 1% to ABDOMINAL DISCOMFORT. This represents approximately 1.8% of all 323,718 adverse event reports for this drug.

Patients taking DICLOFENAC SODIUM TOPICAL GEL, 1% who experience abdominal discomfort should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ABDOMINAL DISCOMFORT5,803 of 323,718 reports

ABDOMINAL DISCOMFORT is a less commonly reported adverse event for DICLOFENAC SODIUM TOPICAL GEL, 1%, but still significant enough to appear in the safety profile.

Other Side Effects of DICLOFENAC SODIUM TOPICAL GEL, 1%

In addition to abdominal discomfort, the following adverse reactions have been reported for DICLOFENAC SODIUM TOPICAL GEL, 1%:

Other Drugs Associated with ABDOMINAL DISCOMFORT

The following drugs have also been linked to abdominal discomfort in FDA adverse event reports:

ABATACEPTACETAMINOPHEN AND CODEINEACETAMINOPHEN AND IBUPROFENACETAMINOPHEN, ASPIRIN, AND CAFFEINEACETAMINOPHEN, ASPIRIN, CAFFEINEACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINEACETAMINOPHEN, CAFFEINEACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDEACTIVATED CHARCOALADALIMUMAB AATYADALIMUMAB ADAZADALIMUMAB FKJPALENDRONATE SODIUMALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONEANTACIDAPIS MELLIFERAAPREMILASTASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE

Frequently Asked Questions

Does DICLOFENAC SODIUM TOPICAL GEL, 1% cause ABDOMINAL DISCOMFORT?

ABDOMINAL DISCOMFORT has been reported as an adverse event in 5,803 FDA reports for DICLOFENAC SODIUM TOPICAL GEL, 1%. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ABDOMINAL DISCOMFORT with DICLOFENAC SODIUM TOPICAL GEL, 1%?

ABDOMINAL DISCOMFORT accounts for approximately 1.8% of all adverse event reports for DICLOFENAC SODIUM TOPICAL GEL, 1%, making it a notable side effect.

What should I do if I experience ABDOMINAL DISCOMFORT while taking DICLOFENAC SODIUM TOPICAL GEL, 1%?

If you experience abdominal discomfort while taking DICLOFENAC SODIUM TOPICAL GEL, 1%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

DICLOFENAC SODIUM TOPICAL GEL, 1% Full ProfileAll Drugs Causing ABDOMINAL DISCOMFORTBluePoint Laboratories Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.